Monitoring inflammation in CF

[1]  F. Accurso,et al.  Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction. , 2001, American journal of respiratory and critical care medicine.

[2]  J. Christman,et al.  Dysregulated Cytokine Production in Human Cystic Fibrosis Bronchial Epithelial Cells , 2001, Inflammation.

[3]  J. Clancy,et al.  A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. , 2001, Human gene therapy.

[4]  C. Scriver,et al.  The Metabolic and Molecular Bases of Inherited Disease, 8th Edition 2001 , 2001, Journal of Inherited Metabolic Disease.

[5]  J. Christman,et al.  Exaggerated Activation of Nuclear Factor- κ B and Altered I κ B- β Processing in Cystic Fibrosis Bronchial Epithelial Cells , 2000 .

[6]  A. Ionescu,et al.  Bone density, body composition, and inflammatory status in cystic fibrosis. , 2000, American journal of respiratory and critical care medicine.

[7]  S. de Bentzmann,et al.  Inflammation and infection in naive human cystic fibrosis airway grafts. , 2000, American journal of respiratory cell and molecular biology.

[8]  T. Kelley,et al.  In vivo alterations of IFN regulatory factor-1 and PIAS1 protein levels in cystic fibrosis epithelium. , 2000, The Journal of clinical investigation.

[9]  R. Moss,et al.  Cytokine dysregulation in activated cystic fibrosis (CF) peripheral lymphocytes , 2000, Clinical and experimental immunology.

[10]  M. Schwarz,et al.  TGF-β1 genotype and accelerated decline in lung function of patients with cystic fibrosis , 2000, Thorax.

[11]  L. Ho,et al.  Measurement of inflammatory markers in the breath condensate of children with cystic fibrosis. , 2000, The European respiratory journal.

[12]  D. Dusser,et al.  High Susceptibility for Cystic Fibrosis Human Airway Gland Cells to Produce IL-8 Through the IκB Kinase α Pathway in Response to Extracellular NaCl Content1 , 2000, The Journal of Immunology.

[13]  A. Kharazmi,et al.  The immune response to chronic Pseudomonas aeruginosa lung infection in cystic fibrosis patients is predominantly of the Th2 type , 2000, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[14]  M. Konstan,et al.  IL-10 attenuates excessive inflammation in chronic Pseudomonas infection in mice. , 1999, American journal of respiratory and critical care medicine.

[15]  W. Mosgoeller,et al.  Cytokine expression in bronchial biopsies of cystic fibrosis patients with and without acute exacerbation. , 1999, The European respiratory journal.

[16]  A. Korngreen,et al.  Extracellular sodium regulates airway ciliary motility by inhibiting a P2X receptor , 1999, Nature.

[17]  J. Cavaillon,et al.  Distinct sputum cytokine profiles in cystic fibrosis and other chronic inflammatory airway disease. , 1999, The European respiratory journal.

[18]  M. Konstan,et al.  Altered respiratory epithelial cell cytokine production in cystic fibrosis. , 1999, The Journal of allergy and clinical immunology.

[19]  S. Randell,et al.  Evidence for Periciliary Liquid Layer Depletion, Not Abnormal Ion Composition, in the Pathogenesis of Cystic Fibrosis Airways Disease , 1998, Cell.

[20]  J. Hull,et al.  Contribution of genetic factors other than CFTR to disease severity in cystic fibrosis , 1998, Thorax.

[21]  S. Thorgeirsson,et al.  Transforming Growth Factor-β1 in Plasma and Liver of Children with Liver Disease , 1998, Pediatric Research.

[22]  J. Zahm,et al.  Selective up-regulation of chemokine IL-8 expression in cystic fibrosis bronchial gland cells in vivo and in vitro. , 1998, The American journal of pathology.

[23]  J. Emerson,et al.  Microbiology of sputum from patients at cystic fibrosis centers in the United States. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  J. Elborn,et al.  Circulating immunoreactive interleukin-6 in cystic fibrosis. , 1998, American journal of respiratory and critical care medicine.

[25]  A J Ratner,et al.  Activation of NF-kappaB by adherent Pseudomonas aeruginosa in normal and cystic fibrosis respiratory epithelial cells. , 1998, The Journal of clinical investigation.

[26]  R. Stockley,et al.  The chemotactic activity of sputum from patients with bronchiectasis. , 1998, American journal of respiratory and critical care medicine.

[27]  M. Merten,et al.  Altered cytokine production by cystic fibrosis tracheal gland serous cells , 1997, Infection and immunity.

[28]  J. Carlin,et al.  Lower airway inflammation in infants and young children with cystic fibrosis. , 1997, American journal of respiratory and critical care medicine.

[29]  D. Corry,et al.  IL-10 improves lung injury and survival in Pseudomonas aeruginosa pneumonia. , 1997, Journal of immunology.

[30]  H. Tilg,et al.  IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. , 1997, Immunology today.

[31]  N. Klein,et al.  Randomised controlled trial of inhaled corticosteroids (fluticasone propionate) in cystic fibrosis , 1997, Archives of disease in childhood.

[32]  Melvin Berger,et al.  Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology , 1997, Pediatric pulmonology.

[33]  J. Rygaard,et al.  Chronic Pseudomonas aeruginosa lung infection is more severe in Th2 responding BALB/c mice compared to Th1 responding C3H/HeN mice , 1997, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[34]  D. Koller,et al.  Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity. , 1997, American journal of respiratory and critical care medicine.

[35]  T. Noah,et al.  Nasal and bronchoalveolar lavage fluid cytokines in early cystic fibrosis. , 1997, The Journal of infectious diseases.

[36]  James M. Wilson,et al.  Human β-Defensin-1 Is a Salt-Sensitive Antibiotic in Lung That Is Inactivated in Cystic Fibrosis , 1997, Cell.

[37]  M. Kemna,et al.  Reduced IL‐10 secretion by CD4+ T lymphocytes expressing mutant cystic fibrosis transmembrane conductance regulator (CFTR) , 1996, Clinical and experimental immunology.

[38]  R. Auckenthaler,et al.  Aerosolized rhDNase in cystic fibrosis: effect on leucocyte proteases in sputum. , 1996, The European respiratory journal.

[39]  E. Greenberg,et al.  Cystic Fibrosis Airway Epithelia Fail to Kill Bacteria Because of Abnormal Airway Surface Fluid , 1996, Cell.

[40]  P. Shah,et al.  The effects of recombinant human DNase on neutrophil elastase activity and interleukin-8 levels in the sputum of patients with cystic fibrosis. , 1996, The European respiratory journal.

[41]  J. Rygaard,et al.  Interferon‐gamma (IFN‐γ) treatment decreases the inflammatory response in chronic Pseudomonas aeruginosa pneumonia in rats , 1996, Clinical and experimental immunology.

[42]  J. Goldberg,et al.  Role of Mutant CFTR in Hypersusceptibility of Cystic Fibrosis Patients to Lung Infections , 1996, Science.

[43]  P. Salvà,et al.  TNF‐α, IL‐8, soluble ICAM‐1, and neutrophils in sputum of cystic fibrosis patients , 1996 .

[44]  M. Konstan,et al.  Inflammatory cytokines in cystic fibrosis lungs. , 1995, American journal of respiratory and critical care medicine.

[45]  M. Konstan,et al.  Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis. , 1995, American journal of respiratory cell and molecular biology.

[46]  M. Weinberger,et al.  The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis , 1995, Pediatric pulmonology.

[47]  P. Phelan,et al.  Lower respiratory infection and inflammation in infants with newly diagnosed cystic fibrosis , 1995, BMJ.

[48]  Kwang Woo Kim,et al.  Prominent neutrophilic inflammation in sputum from subjects with asthma exacerbation. , 1995, The Journal of allergy and clinical immunology.

[49]  D. Riches,et al.  Early pulmonary inflammation in infants with cystic fibrosis. , 1995, American journal of respiratory and critical care medicine.

[50]  R. Crystal,et al.  IL-6 release and airway administration of human CFTR cDNA adenovirus vector , 1995, Nature Medicine.

[51]  J. Stamler,et al.  Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[52]  Lee F. Peng,et al.  Plasma interleukin‐1α and β, tumor necrosis factor‐α, and lipopolysaccharide concentrations during pulmonary exacerbations of cystic fibrosis , 1994 .

[53]  J. Elborn,et al.  On tumor necrosis factor alpha in CF. , 1994, Pediatric pulmonology.

[54]  J. Elborn,et al.  The host inflammatory response prior to death in patients with cystic fibrosis and chronic Pseudomonas aeruginosa infection. , 1993, Respiratory medicine.

[55]  A. Prince,et al.  Pseudomonas aeruginosa pili bind to asialoGM1 which is increased on the surface of cystic fibrosis epithelial cells. , 1993, The Journal of clinical investigation.

[56]  J. Warner,et al.  Interleukin-8 Concentrations Are Elevated in Bronchoalveolar Lavage, Sputum, and Sera of Children with Cystic Fibrosis , 1993, Pediatric Research.

[57]  D. Vergani,et al.  Serum interleukin-1 alpha and soluble interleukin-2 receptor concentrations in cystic fibrosis. , 1993, Archives of disease in childhood.

[58]  K. Bendtzen,et al.  Cytokines in sputum and serum from patients with cystic fibrosis and chronic pseudomonas aeruginosa infection as markers of destructive inflammation in the lungs. , 1993, Pediatric pulmonology.

[59]  P. Greally,et al.  Sputum tumour necrosis factor-alpha and leukotriene concentrations in cystic fibrosis. , 1993, Archives of disease in childhood.

[60]  R. Crystal,et al.  Modulation of airway inflammation in cystic fibrosis. In vivo suppression of interleukin-8 levels on the respiratory epithelial surface by aerosolization of recombinant secretory leukoprotease inhibitor. , 1992, The Journal of clinical investigation.

[61]  R. Crystal,et al.  Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. , 1992, The Journal of clinical investigation.

[62]  R. Crystal,et al.  Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency. Spontaneous release of leukotriene B4 by alveolar macrophages. , 1991, The Journal of clinical investigation.

[63]  F. Accurso,et al.  Early bacteriologic, immunologic, and clinical courses of young infants with cystic fibrosis identified by neonatal screening. , 1991, The Journal of pediatrics.

[64]  D. Norman,et al.  Plasma tumour necrosis factor alpha in cystic fibrosis. , 1991, Thorax.

[65]  M. Berger,et al.  Neutrophil elastase cleaves C3bi on opsonized pseudomonas as well as CR1 on neutrophils to create a functionally important opsonin receptor mismatch. , 1990, The Journal of clinical investigation.

[66]  George,et al.  Neutrophil elastase and cathepsin G stimulate secretion from cultured bovine airway gland serous cells. , 1990, The Journal of clinical investigation.

[67]  G. Redding,et al.  Endobronchial Infection in Cystic Fibrosis , 1989, Acta paediatrica Scandinavica. Supplement.

[68]  J. Vilček,et al.  Tumor necrosis factor and interleukin 1: cytokines with multiple overlapping biological activities. , 1987, Laboratory investigation; a journal of technical methods and pathology.

[69]  D. Geddes,et al.  Inflammation in cystic fibrosis airways: relationship to increased bacterial adherence. , 2001, The European respiratory journal.

[70]  R. Lark,et al.  Adverse alterations in bone metabolism are associated with lung infection in adults with cystic fibrosis. , 2000, American journal of respiratory and critical care medicine.

[71]  B. Wretlind,et al.  TNF-alpha and IL-8 in consecutive sputum samples from cystic fibrosis patients during antibiotic treatment. , 2000, Scandinavian journal of infectious diseases.

[72]  T. Noah,et al.  Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. , 1999, American journal of respiratory and critical care medicine.

[73]  A. Pukhalsky,et al.  Inflammatory markers in cystic fibrosis patients with lung Pseudomonas aeruginosa infection. , 1999, Mediators of inflammation.

[74]  J. Hull,et al.  Elemental content of airway surface liquid from infants with cystic fibrosis. , 1998, American journal of respiratory and critical care medicine.

[75]  D. Vergani,et al.  Interleukin-1cx, soluble interleukin-2 receptor, andIgGconcentrations incystic fibrosis treated withprednisolone , 1994 .

[76]  E. Levy,et al.  Circulating tumor necrosis factor-alpha levels and lipid abnormalities in patients with cystic fibrosis. , 1993, Pediatric research.

[77]  James M. Wilson,et al.  Submucosal glands are the predominant site of CFTR expression in the human bronchus , 1992, Nature Genetics.

[78]  M. Brown,et al.  Circulating levels of tumor necrosis factor and interleukin‐1 in cystic fibrosis , 1991, Pediatric pulmonology.

[79]  D. Remick,et al.  Intratracheal injection of endotoxin and cytokines. II. Interleukin-6 and transforming growth factor beta inhibit acute inflammation. , 1991, The American journal of pathology.